What is Samvardhana Motherson Health Solution Limited (SMHS)'s cybersecurity risk score?

Samvardhana Motherson Health Solution Limited (SMHS) has an AI-generated cybersecurity risk score of 751 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Samvardhana Motherson Health Solution Limited (SMHS) experienced?

According to Rankiteo, Samvardhana Motherson Health Solution Limited (SMHS) currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Samvardhana Motherson Health Solution Limited (SMHS) been affected by any supply chain cyber incidents ?

According to Rankiteo, Samvardhana Motherson Health Solution Limited (SMHS) has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Samvardhana Motherson Health Solution Limited (SMHS) have SOC 2 Type 1 certification ?

According to Rankiteo, Samvardhana Motherson Health Solution Limited (SMHS) is not certified under SOC 2 Type 1.

Does Samvardhana Motherson Health Solution Limited (SMHS) have SOC 2 Type 2 certification ?

According to Rankiteo, Samvardhana Motherson Health Solution Limited (SMHS) does not hold a SOC 2 Type 2 certification.

Does Samvardhana Motherson Health Solution Limited (SMHS) have PCI DSS certification ?

According to Rankiteo, Samvardhana Motherson Health Solution Limited (SMHS) does not currently maintain PCI DSS compliance.

Does Samvardhana Motherson Health Solution Limited (SMHS) comply with HIPAA ?

According to Rankiteo, Samvardhana Motherson Health Solution Limited (SMHS) is not compliant with HIPAA regulations.

Does Samvardhana Motherson Health Solution Limited (SMHS) have ISO 27001 certification ?

According to Rankiteo,Samvardhana Motherson Health Solution Limited (SMHS) is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Samvardhana Motherson Health Solution Limited (SMHS) operate in ?

Samvardhana Motherson Health Solution Limited (SMHS) operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Samvardhana Motherson Health Solution Limited (SMHS) have ?

Samvardhana Motherson Health Solution Limited (SMHS) employs approximately 46 people worldwide.

Does Samvardhana Motherson Health Solution Limited (SMHS) own any subsidiaries ?

Samvardhana Motherson Health Solution Limited (SMHS) presently has no subsidiaries across any sectors.

How many LinkedIn followers does Samvardhana Motherson Health Solution Limited (SMHS) have ?

Samvardhana Motherson Health Solution Limited (SMHS)'s official LinkedIn profile has approximately 4,111 followers.

Does Samvardhana Motherson Health Solution Limited (SMHS) have a Crunchbase profile ?

No, Samvardhana Motherson Health Solution Limited (SMHS) does not have a profile on Crunchbase.

Does Samvardhana Motherson Health Solution Limited (SMHS) have a LinkedIn profile ?

Yes, Samvardhana Motherson Health Solution Limited (SMHS) maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/samvardhanamothersonhealthsolution.

How many peer or competitor companies does Samvardhana Motherson Health Solution Limited (SMHS) have ?

Samvardhana Motherson Health Solution Limited (SMHS) has an estimated 5,769 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

SMHSL

Boost Score +25 with badge (5 left)

751

/1000

Fair

776

/1000

Fair

Samvardhana Motherson Health Solution Limited (SMHS) Vendor Cyber Rating & Cyber Score

motherson.com

Add Your Compliance Badge

We are part of Samvardhana Motherson Group (SMG), one of the most diversified auto ancillary Groups headquartered in India with a global footprint. A key supplier to all major car manufacturers in the world, the USD 11.5 billion Group provides integrated full system solutions right from design to delivery to a spectrum of industries. SMG has over 270 facilities supported by design centres and support offices spread across 41 countries employing over 135,000 personnel. Samvardhana Motherson Health Solution Limited (SMHS), an innovative digital solutions company that has been continuously changing the pharma landscape through forward thinking, innovative collaborations, exceptional service, disruptive thinking and best in class technology.

SMHSL

Samvardhana Motherson Health Solution Limited (SMHS) CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

SMHSL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for SMHSL

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Samvardhana Motherson Health Solution Limited (SMHS) in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Samvardhana Motherson Health Solution Limited (SMHS) in 2026.

Incident Types SMHSL vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Samvardhana Motherson Health Solution Limited (SMHS) in 2026.

Incident History - SMHSL (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Samvardhana Motherson Health Solution Limited (SMHS) Subsidiaries

SMHSL

Pharmaceutical Manufacturing

Website: http://www.smhs.motherson.com

Company Size: 46

Motherson GroupMotor Vehicle Manufacturing

Motherson Technology ServicesIT Services and IT Consulting

Motherson Technology Services USAIT Services and IT Consulting

Motherson Technology Services GermanyIT Services and IT Consulting

Motherson Technology Services United KingdomInformation Technology & Services

Motherson Technology Services JapanITサービス・ITコンサルティング

Motherson Technology Services SpainServicios y consultoría de TI

SMP Automotive GlobalMotor Vehicle Manufacturing

PKC GroupMotor Vehicle Manufacturing

SMR Automotive GlobalMotor Vehicle Manufacturing

Motherson InnovationsMotor Vehicle Manufacturing

Motherson Australia (SMR & MEPL)Appliances, Electrical, and Electronics Manufacturing

Motherson AerospaceAviation and Aerospace Component Manufacturing

SMIA Automotive GlobalAutomotive

Wisetime OyIT Services and IT Consulting

Loading…

Samvardhana Motherson Health Solution Limited (SMHS) Similar Companies

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Parexel

parexel.com

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Loading…

NEWS

Samvardhana Motherson Health Solution Limited (SMHS) CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-95828

SUMMARY

A vulnerability was determined in Mstfakts College-Management-System. This affects the function session_start of the file Front-end/server.php of the component Authentication. Executing a manipulation can lead to session fixiation. It is possible to launch the attack remotely. The exploit has been publicly disclosed and may be utilized. This product takes the approach of rolling releases to provide continious delivery. Therefore, version details for affected and updated releases are not available. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-95820

SUMMARY

A vulnerability was found in anirbandutta9 College-Notes-Gallery up to 8c1cf3d98f30982d069c88ca172612c001eb39f6. Affected by this issue is some unknown functionality of the file /dashboard/userprofile.php?section=admin1. Performing a manipulation of the argument image results in unrestricted upload. It is possible to initiate the attack remotely. The exploit has been made public and could be used. This product is using a rolling release to provide continious delivery. Therefore, no version details for affected nor updated releases are available. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-61685

SUMMARY

ReactPress is a publishing system for React developers. Prior to version 3.7.0, ReactPress API list endpoints build TypeORM `QueryBuilder` conditions using unsanitized HTTP query parameter names as SQL column identifiers (e.g. `` `article.${key}` ``). TypeORM parameterizes values but not column names, allowing unauthenticated attackers to inject SQL through crafted query string keys. Version 3.7.0 contains a patch. As a workaround, allowlist allowed filter column names before interpolating into SQL.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-57576

SUMMARY

plone.app.dexterity is a content-type system for the Plone content management system, and plone.app.contenttypes provides Plone’s Dexterity-based content types. Plone.app.dexterity versions through 3.2.2, 4.0.0 through 4.1.2, and 5.0.0, and plone.app.contenttypes versions through 3.0.11, 4.0.0 through 4.0.9, and 5.0.0 are vulnerable to denial of service because an authenticated user can create content with excessively long titles, descriptions, or uploaded-file names, causing Plone to become unresponsive and potentially making the resulting content difficult to edit or delete. The vulnerability is patched in plone.app.dexterity versions 3.2.3, 4.1.3, and 5.0.1, and in plone.app.contenttypes versions 3.0.12, 4.0.10, and 5.0.1.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

CVE-2026-18176

SUMMARY

IBM Financial Transaction Manager (FTM) for RedHat OpenShift could allow a remote attacker to obtain sensitive information due to cleartext transmission of sensitive information.

Published

Date2026-09-22

Updated

Date2026-09-22

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: LOW

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N

Impact Score

Exploitability

2.8

REFERENCES

https://www.ibm.com/support/pages/node/7288641

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Samvardhana Motherson Health Solution Limited (SMHS) Vendor Cyber Rating & Cyber Score

SMHSL A.I CyberSecurity Scoring

Samvardhana Motherson Health Solution Limited (SMHS) CyberSecurity News & History

SMHSL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for SMHSL

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types SMHSL vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - SMHSL (X = Date, Y = Severity)

Samvardhana Motherson Health Solution Limited (SMHS) Subsidiaries

SMHSL

Samvardhana Motherson Health Solution Limited (SMHS) Similar Companies

Johnson & Johnson Innovative Medicine

Takeda

MENARINI Group

Parexel

AUROBINDO PHARMA LTD

Teva Pharmaceuticals

Bristol Myers Squibb

MSD

Hikma Pharmaceuticals

Samvardhana Motherson Health Solution Limited (SMHS) CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Samvardhana Motherson Health Solution Limited (SMHS) CyberSecurity News & History

SMHSL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for SMHSL

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types SMHSL vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - SMHSL (X = Date, Y = Severity)

Samvardhana Motherson Health Solution Limited (SMHS) Subsidiaries

SMHSL

Samvardhana Motherson Health Solution Limited (SMHS) Similar Companies

Johnson & Johnson Innovative Medicine

Takeda

MENARINI Group

Parexel

AUROBINDO PHARMA LTD

Teva Pharmaceuticals

Bristol Myers Squibb

MSD

Hikma Pharmaceuticals

Samvardhana Motherson Health Solution Limited (SMHS) CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo